Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice

Infection and Immunity

Volumn 76, Issue 6, 2008, Pages 2696-2705

  Medina, Marcela ^a   Villena, Julio ^a,b   Vintiñi, Elisa ^a   Hebert, Elvira María ^a   Raya, Raúl ^a   Alvarez, Susana ^a,b  

^a CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NISIN; PNEUMOCOCCAL PROTECTIVE PROTEIN A; PNEUMOCOCCAL PROTECTIVE PROTEIN A ANTIBODY; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BACTERIAL CELL WALL; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CELL SURFACE; CONTROLLED STUDY; CROSS REACTION; GENE EXPRESSION; IMMUNODETECTION; INFECTION RESISTANCE; LACTOCOCCUS LACTIS; LUNG LAVAGE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; TREATMENT OUTCOME; AGING; ANIMAL; ANTIBODY AFFINITY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MOLECULAR CLONING;

ADMINISTRATION, INTRANASAL; AGING; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; BACTERIAL PROTEINS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, BACTERIAL; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS; MICE; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 46249119212     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00119-08     Document Type: Article

References (33)

1. Anttila, M., J. Eskola, H. Åhman, and H. Käyhty. 1998. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J. Infect. Dis. 177:1614-1621.
2. Audouy, S. A. L., M. L. van Roosmalen, J. Neef, R. Kanninga, E. Post, M. van Deemter, H. Metselaar, S. van Selm, G. T. Robillard, K. J. Leenhouts, and P. W. M. Hermans. 2006. Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization. Vaccine 24:5434-5441.
3. Barrios, C., P. Brawand, M. Berney, C. Brandt, P. H. Lambert, and C. A. Siegrist. 1996. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 26:1489-1496.
4. Bermudez-Humarán, L. G., N. G. Cortes-Perez, Y. Le Loir, J. M. Alcocer-González, R. S. Tamez-Guerra, R. Montes de Oca-Luna, and P. Langella. 2004. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J. Med. Microbiol. 53:427-433.
5. Bernatoniene, J., and A. Finn. 2005. Advances in pneumococcal vaccines: advantages for infants and children. Drugs 65:229-255.
6. Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J. Hansen, L. Elvin, K. Ensor, J. Hackell, G. Siber, F. Malinoski, D. Madore, I. Chang, R. Kohberger, W. Watson, R. Austrian, and K. Edwards. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19:187-195.
7. Bogaert, D., P. W. M. Hermans, P. V. Adrian, and R. Groot. 2004. Pneumococcal vaccines: an update on current strategies. Vaccine 22:2209-2220.
8. Bogaert, D., R. Groot, and P. W. M. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4:144-154.
9. Briles, D. E., R. C. Tart, E. Swiatlo, J. P. Dillard, P. Smith, K. A. Benton, B. A. Ralph, A. Brooks-Walter, M. J. Crain, S. K. Hollingshead, and L. S. McDaniel. 1998. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11:645-657.
10. Buccato, S., D. Maione, C. D. Rinaudo, G. Volpini, A. R. Taddei, R. Rosini, J. L. Telford, G. Grandi, and I. Margarit. 2006. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease. J. Infect. Dis. 194:331-340.
11. Centers for Disease Control and Prevention. 2000. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb. Mortal. Wkly. Rep. 49:1-38.
12. Cortes-Perez, N. G., L. G. Bermudez-Humaran, Y. Le Loir, C. Rodriguez-Padilla, A. Gruss, O. Saucedo-Cardenas, P. Langella, and R. Montes-de-Oca-Luna. 2003. Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol. Lett. 229:37-42.
13. Fujihashi, K., T. Koga, F. W. van Ginkel, Y. Hagiwara, and J. R. McGhee. 2002. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 20:2431-2438.
14. Gor, D. O., X. Ding, D. E. Briles, M. R. Jacobs, and N. S. Greenspan. 2005. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect. Immun. 73:1304-1312.
15. Green, B. A., Y. Zhang, A. W. Masi, V. Barniak, M. Wetherell, R. P. Smith, M. S. Reddy, and D. Zhu. 2005. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Infect. Immun. 73:981-989.
16. Hanniffy, S. B., A. T. Carter, E. Hitchin, and J. M. Wells. 2007. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J. Infect. Dis. 195:185-193.
17. Hausdorff, W. P., D. R. Feikin, and K. P. Klugman. 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5:83-93.
18. Hebert, H. M., R. Raya, and G. S. de Giori. 2000. Nutritional requirements and nitrogen-dependent regulation of proteinase activity of Lactobacillus helveticus CRL 1062. Appl. Environ. Microbiol. 66:5316-5321.
19. Jackson, C. R. 2002. Clinical experience with pneumococcal conjugate vaccines in infants and children. J. Am. Osteopath. Assoc. 102:431-436.
20. Le Loir, Y., V. Azevedo, S. C. Oliveira, D. A. Freitas, A. Miyoshi, L. G. Bermudez-Humaran, S. Nouaille, L. A. Ribeiro, S. Leclercq, J. E. Gabriel, V. D. Guimaraes, M. N. Oliveira, C. Charlier, M. Gautier, and P. Langella. 2005. Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb. Cell Fact. 4:2-13.
21. Mawas, F., I. M. Feavers, and M. J. Corbel. 2001. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1:Th2 cytokine profile and IgG subclass response to pneumococcal-CRM197 conjugate vaccines in a murine model. Vaccine 19:1159-1166.
22. Mollerach, M., M. Regueira, L. Bonofiglio, R. Callejo, J. Pace, J. L. Di Fabio, S. Hollingshead, D. Briles, and the Streptococcus pneumoniae Working Group. 2004. Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol. Infect. 132:177-184.
23. Musher, D. M., A. J. Chapman, A. Goree, S. Jonsson, D. Briles, and R. E. Baughn. 1986. Natural and vaccine-related immunity to Streptococcus pneumoniae. J. Infect. Dis. 154:245-256.
24. Norton, P. M., H. W. Brown, J. M. Wells, A. M. Macpherson, P. W. Wilson, and R. W. Le Page. 1996. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis. FEMS Immunol. Med. Microbiol. 14:167-177.
25. Racedo, S., J. Villena, M. Medina, G. Agüero, V. Rodríguez, and S. Alvarez. 2006. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection. Microbes Infect. 8:2359-2366.
26. Reveneau, N., M. C. Geoffroy, C. Locht, P. Chagnaud, and A. Mercenier. 2002. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 20:1769-1777.
27. Robinson, K., L. M. Chamberlain, M. C. Lopez, C. M. Rush, H. Marcotte, R. W. F. Le Page, and J. M. Wells. 2004. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect. Immun. 72:2753-2761.
28. Sambrook, J., E. F. Fritch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Sarno Oliveira, M. L., A. P. Mattos Areas, I. Barros Campos, V. Monedero, G. Perez-Martines, E. M. Miyaji, L. C. Cerqueira Leite, A. K. Araujo, and P. Lee Ho. 2006. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect. 8:1016-1024.
30. Siegrist, C. A. 2001. Neonatal and early life vaccinology. Vaccine 19:3331-3346.
31. Tai, S. S. 2006. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit. Rev. Microbiol. 32:139-153.
32. Twigg, H. L. 2005. Humoral immune defense (antibodies): recent advances. Proc. Am. Thorac. Soc. 2:417-421.
33. Villena, J., S. Racedo, G. Agüero, E. Bru, M. Medina, and S. Alvarez. 2005. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J. Nutr. 135:1462-1469.